<?xml version="1.0" encoding="UTF-8"?>
<p>Breast cancer is cancer that occurs in the epithelial tissue of the breast gland.
 <sup>[
  <xref rid="R1" ref-type="bibr">1</xref>]
 </sup> In recent years, the incidence rates of female breast cancer have a slight increase and has surpassed lung cancer as the most commonly cancer worldwide.
 <sup>[
  <xref rid="R1" ref-type="bibr">1</xref>,
  <xref rid="R2" ref-type="bibr">2</xref>]
 </sup> Nowadays, surgery, chemotherapy, immunotherapy and hormone, radiation and targeted therapies are acknowledged as common treatments in breast cancer.
 <sup>[
  <xref rid="R3" ref-type="bibr">3</xref>–
  <xref rid="R6" ref-type="bibr">6</xref>]
 </sup> Although chemotherapy, as a commonly applied and important treatment, has significant improved overall survival in many types of cancer, it also can damage healthy cells and tissues of patients, which results in adverse outcomes that negatively affect a therapy compliance with cancer treatment.
 <sup>[
  <xref rid="R7" ref-type="bibr">7</xref>]
 </sup> Gastrointestinal toxicity is a common side effect characterized by nausea, vomiting, bloating, diarrhea and constipation. It will lead to delays, adjustments, and discontinuation of treatment which is greatly impacting the quality of life in cancer patients.
 <sup>[
  <xref rid="R8" ref-type="bibr">8</xref>–
  <xref rid="R10" ref-type="bibr">10</xref>]
 </sup> The incidence is about 63% to 78% in patients receiving chemotherapy.
 <sup>[
  <xref rid="R11" ref-type="bibr">11</xref>]
 </sup> Furthermore, among cancer survivors, the incidence of chronic gastrointestinal toxicity, like constipation or diarrhea, has been estimated to be still as high as 49%, and the disorder would last for ten years after the treatment ended.
</p>
